<DOC>
	<DOCNO>NCT00065117</DOCNO>
	<brief_summary>The purpose study assess Safety , Tolerability Efficacy ZD6126 Combination Oxaliplatin , 5-Fluorouracil Leucovorin Subjects Metastatic Colorectal Cancer .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy ZD6126 Combination With Oxaliplatin , 5-Fluorouracil Leucovorin Subjects With Metastatic Colorectal Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Metastatic colorectal carcinoma Suitable firstline treatment metastatic disease Peripheral neuropathy great Grade 1 Adjuvant therapy within 6 month prior study treatment Prior oxaliplatin Prior pelvic whole abdomen radiation Any history coronary angioplasty history myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>metastatic</keyword>
	<keyword>colorectal</keyword>
	<keyword>first-line</keyword>
	<keyword>adjuvant</keyword>
	<keyword>cancer</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumors</keyword>
	<keyword>Neoplasms , Colorectal</keyword>
</DOC>